Types, Treatments, and Challenges of Thalassemia

Thalassemia is a severe genetic blood disorder in which red blood cells are prematurely destroyed due to the production of abnormal hemoglobin within the body. Consequently, the patient suffers from chronic anemia and requires frequent blood transfusions to sustain life.

Things You Will Need

• N/A

Method

Types of Thalassemia

Thalassemia primarily occurs in three forms: Minor, Intermedia, and Major. Among these, Thalassemia Major is the most severe form, requiring the patient to undergo regular blood transfusions throughout their life. This condition is referred to as TDT (Transfusion-Dependent Thalassemia).

Current Treatments and Challenges

These children require blood transfusions 2–3 times every month, which leads to an accumulation of iron in the body. If left uncontrolled, this can increase the risk of complications such as heart problems, stunted growth, hormonal imbalances, diabetes, and others.

Is a Complete Cure Possible?

Bone marrow transplantation is the only permanent cure for Thalassemia; this procedure is currently being performed successfully across the country with financial assistance from various government and non-governmental organizations and schemes.

Disease Burden and Carrier Rate

The carrier rate in the country is approximately 3–4 percent, although in certain communities, this rate has been observed to range between 5 and 17 percent. There are approximately 100,000 to 150,000 Thalassemia patients in the country, and 10,000 to 15,000 children are born with this disease every year.

Key Considerations:

Bone marrow transplantation yields the best results when performed between the ages of 2 and 7 years. While finding a perfect HLA match can be challenging, the option of a haplo-identical donor is available. A period of one year of post-transplant monitoring is mandatory. Transplants are typically avoided during the monsoon season due to the increased risk of infection.

A New Hope—Gene Therapy:

Currently, gene therapy remains an experimental and expensive treatment option, primarily available in developed nations. Thanks to advancements in medical science, the outlook for children with Thalassemia has improved significantly; with appropriate treatment, patients with Thalassemia can lead normal lives.